CVS Health inks clinical affiliations with four healthcare organizations
WOONSOCKET, R.I. — CVS Health has entered into new clinical affiliations with Sutter Health in California, Millennium Physician Group in Florida, Bryan Health Connect in Nebraska and Mount Kisco Medical Group, PC in New York. These new affiliations bring the total number of clinical collaborations for CVS Health and MinuteClinic to nearly 60 major health systems and healthcare providers across the country.
Through these clinical affiliations, CVS Health will provide prescription and visit information to the participating health care organizations by enabling communication between our secured electronic health record systems, which will help enhance clinical care for patients served by the partnering organizations. In addition, patients will continue to have access to clinical support, medication counseling, chronic disease monitoring and wellness programs at CVS/pharmacy stores and MinuteClinic, the retail medical clinic of CVS Health.
"In this era of health care reform, we are pleased to work with these health care organizations to develop collaborative programs that enhance access to patient care, improve health outcomes and lower health care costs in the communities they serve," stated Troyen Brennan, chief medical officer, CVS Health. "By allowing our electronic health records and information systems to communicate and share important information about the patients we collectively serve, we will have a more comprehensive view of our patients, which can aid in health care decision making and help ensure patients adhere to important medications for chronic diseases."
CVS/pharmacy currently has more than 7,800 retail pharmacy locations across the United States where CVS pharmacists provide counseling to patients to help them be adherent to their chronic disease medications. In addition, there are nearly 1,000 MinuteClinic walk-in medical clinics available at CVS/pharmacy retail stores. The clinics are staffed by nurse practitioners and physician assistants who provide treatment for common family illnesses and administer wellness and prevention services, including health condition monitoring for patients with chronic diseases.
Affiliates' health care providers will receive data on interventions conducted by CVS pharmacists to improve medication adherence for their patients. The affiliation also encourages collaboration between the health care providers and MinuteClinic providers to improve coordination of care for patients seen at MinuteClinic locations. Through this collaboration, the affiliate organizations and MinuteClinic practitioners will also work together on planning strategies around chronic care and wellness. If more comprehensive care is needed, patients can follow up with their primary care provider and have access to the services at the health care provider as appropriate. For those patients who do not have regular access to health care, MinuteClinic provides information to help patients in finding a primary care physician and a greater opportunity for continuity of health care services.
MinuteClinic, CVS/pharmacy and the participating healthcare organizations will begin to work toward streamlining and enhancing communication through their EHR systems. This will include the electronic sharing of messages and alerts from CVS/pharmacy to the health care organizations' physicians regarding medication non-adherence issues. In addition, MinuteClinic will electronically share patient visit summaries with the patient's primary care physician when they are part of an affiliate organization and with the patient's consent. MinuteClinic will continue its standard practice of sending patient visit summaries to primary care providers who are not affiliated with one of these participating healthcare organizations via fax or mail, with patient consent.
FDA issues final guidance on generic drug appearance
Sandoz launches Glatopa as first U.S. Copaxone generic
HOLZKIRCHEN, Germany — Sandoz has launched Glatopa, the first U.S. generic of Teva’s Copaxone (glatiramer acetate injection, 20-mg/ml ), a once-daily treatment for multiple sclerosis. The drug was developed in collaboration with Momenta and approved by the FDA in April.
“Sandoz, together with Momenta, is proud to announce the US market launch of a fully substitutable generic version of this important therapy, following FDA approval,” Sandoz U.S. President Peter Goldschmidt said.
The company is also introducing a patient support service that includes financial assistance for qualifying patients, injection training, and access to nurses for non-clinical questions 24 hours a day.